NCT05577234

Brief Summary

The purpose of this study is to determine whether animal-assisted therapy during 2 care sessions then facilitates conventional ambulatory management without animal assistance in anxious uncooperative children with autism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

March 24, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2024

Completed
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

September 5, 2022

Last Update Submit

March 9, 2026

Conditions

Keywords

Animal-assisted therapychildautism

Outcome Measures

Primary Outcomes (1)

  • Average anxiety

    Average anxiety of the child during the session assessed by the Venham scale modified by Veerkamp measured at the end of the third treatment session (without animal assisted intervention). Score on a scale : Min = 0 Max = 5 : 0 = relaxed, 1 = uneasy, 2 = tense, 3 = unwilling, 4 = very troubled, 5 = totally out of touch

    through study completion, an average of 3 months

Secondary Outcomes (4)

  • Evaluate the success of the care session (complete achievement of the planned objective)

    at the end of each follow-up visit, on average 3 months

  • Validate the use of MEOPA administration

    at the end of each follow-up visit, on average 3 months

  • Assess the types of acts for which animal assisted intervention reduces the child's anxiety

    at the end of each follow-up visit, on average 3 months

  • Assessing the safety of animal assisted intervention for oral care

    at the end of each follow-up visit, on average 3 months

Study Arms (2)

Animal-assisted intervention

EXPERIMENTAL

The dog accompanied by the zootherapist will participate in the care of the sessions. During these sessions, the dog will be brought into the child's presence in the waiting room until the end of the dental consultation.

Other: Animal-assisted interventionBehavioral: Venham scale modified by Veerkamp

Standard care

OTHER

The treatment sessions will only involve the use of conventional behavioural strategies.

Behavioral: Venham scale modified by Veerkamp

Interventions

The dog accompanied by the zootherapist will participate in the care of sessions 1 and 2. During these two sessions, the dog will be present with the child in the waiting room until the end of the dental consultation. Session 3 will take place without the dog being present.The usual management with conventional behavioural strategies and possible administration of MEOPA will be implemented during the 3 treatment sessions.

Animal-assisted intervention

The Venham scale modified by Veerkamp, based on observation of one's behaviour and used in current practice, ranges from 0 (relaxed) to 5 (totally disconnected from the reality of danger).

Animal-assisted interventionStandard care

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Minors aged ≥ 6 to ≤ 17 years,
  • Carriers of Autism Spectrum Disorder.
  • Who accept the presence of the dog
  • Who declare having been in contact with a dog in the past
  • Consent from the child's legal guardians for the child's participation in the study,
  • Be affiliated to a social security scheme in their own name or be the legal guardian of a person with parental authority.
  • A state of health requiring a simple, non-complex dental procedure (preventive, carious, traumatic or orthodontic care, excluding complex surgery in the operating theatre)
  • A state of health requiring a dental treatment protocol consisting of at least 3 scheduled treatment sessions spaced at least 7 days and no more than 21 days apart.

You may not qualify if:

  • Child with dog allergy
  • Cynophobia
  • Who claims never to have been exposed to a dog (allergy risk not assessed)
  • Patient on AME

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Bretonneau - Service d'odontologie

Paris, France

Location

Related Publications (1)

  • Hamdan S, Nguyen J, Abdoul H, Ollivier C, Treluyer JM, Courson F, Jungo S, Salmon B, Fron-Chabouis H, Smail-Faugeron V. Dog Therapy for Dental Care Among Autistic Children: A Randomized Trial. Pediatrics. 2026 Feb 1;157(2):e2025073469. doi: 10.1542/peds.2025-073469.

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Jean-Marc TRELUYER, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2022

First Posted

October 13, 2022

Study Start

March 24, 2023

Primary Completion

March 25, 2024

Study Completion

March 25, 2024

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations